Literature DB >> 12381896

Four novel mutations in the PITX2 gene in patients with Axenfeld-Rieger syndrome.

Jeffrey C Phillips1.   

Abstract

Mutational screening and sequence analysis of the PITX2 gene was performed in four families previously diagnosed with Rieger syndrome. The results of this analysis identified four novel mutations within the coding sequence of PITX2. These mutations were not identified in the sequence of 50 control individuals. Two mutations were found in the homeobox and would be expected to result in nonconservative amino acid changes within the second and third helixes. The remaining two mutations were found in the region downstream of the homeobox and are also predicted to result in missense mutations. In conclusion, mutations within the homeobox sequence and the adjacent coding sequence of PITX2 lead to various Rieger syndrome phenotypes characterized by a high incidence of glaucoma. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12381896     DOI: 10.1159/000065602

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  14 in total

1.  PITX2 AND PITX1 regulate thyrotroph function and response to hypothyroidism.

Authors:  F Castinetti; M L Brinkmeier; D F Gordon; K R Vella; J M Kerr; A H Mortensen; A Hollenberg; T Brue; E C Ridgway; S A Camper
Journal:  Mol Endocrinol       Date:  2011-09-29

2.  A zebrafish model of axenfeld-rieger syndrome reveals that pitx2 regulation by retinoic acid is essential for ocular and craniofacial development.

Authors:  Brenda L Bohnsack; Daniel S Kasprick; Phillip E Kish; Daniel Goldman; Alon Kahana
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-03       Impact factor: 4.799

3.  PITX2 is involved in stress response in cultured human trabecular meshwork cells through regulation of SLC13A3.

Authors:  M Hermina Strungaru; Tim Footz; Yi Liu; Fred B Berry; Pascal Belleau; Elena V Semina; Vincent Raymond; Michael A Walter
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-29       Impact factor: 4.799

4.  Structural and biophysical insights into the ligand-free Pitx2 homeodomain and a ring dermoid of the cornea inducing homeodomain mutant.

Authors:  Thomas Doerdelmann; Douglas J Kojetin; Jamie M Baird-Titus; Laura A Solt; Thomas P Burris; Mark Rance
Journal:  Biochemistry       Date:  2012-01-06       Impact factor: 3.162

5.  Mutations in the nuclear localization sequence of the Aristaless related homeobox; sequestration of mutant ARX with IPO13 disrupts normal subcellular distribution of the transcription factor and retards cell division.

Authors:  Cheryl Shoubridge; May Huey Tan; Tod Fullston; Desiree Cloosterman; David Coman; George McGillivray; Grazia M Mancini; Tjitske Kleefstra; Jozef Gécz
Journal:  Pathogenetics       Date:  2010-01-05

6.  Dental and Craniofacial Anomalies Associated with Axenfeld-Rieger Syndrome with PITX2 Mutation.

Authors:  Simone Dressler; Philipp Meyer-Marcotty; Nicole Weisschuh; Anahita Jablonski-Momeni; Klaus Pieper; Gwendolyn Gramer; Eugen Gramer
Journal:  Case Rep Med       Date:  2010-03-21

7.  An unusual class of PITX2 mutations in Axenfeld-Rieger syndrome.

Authors:  Irfan Saadi; Rafael Toro; Adisa Kuburas; Elena Semina; Jeffrey C Murray; Andrew F Russo
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2006-03

8.  A model for the molecular underpinnings of tooth defects in Axenfeld-Rieger syndrome.

Authors:  Xiao Li; Shankar R Venugopalan; Huojun Cao; Flavia O Pinho; Michael L Paine; Malcolm L Snead; Elena V Semina; Brad A Amendt
Journal:  Hum Mol Genet       Date:  2013-08-23       Impact factor: 6.150

9.  Analysis of RNA splicing defects in PITX2 mutants supports a gene dosage model of Axenfeld-Rieger syndrome.

Authors:  Nicole L Maciolek; Wallace L M Alward; Jeffrey C Murray; Elena V Semina; Mark T McNally
Journal:  BMC Med Genet       Date:  2006-07-11       Impact factor: 2.103

10.  A novel PITX2 mutation in a Chinese family with Axenfeld-Rieger syndrome.

Authors:  Dandan Li; Qingguo Zhu; Hui Lin; Nan Zhou; Yanhua Qi
Journal:  Mol Vis       Date:  2008-12-05       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.